Thomas A. Collet wrote:
>> I apologize if this topic does not meet this newsgroups normal interests. I did check out the current topics of discussion
first. I will not re-post, unless th
> _________________________________________________________________
_______________
>> UNMET OR POORLY-MET MEDICAL NEEDS ADDRESSED BY DRUG DELIVERY TECHNOLOGY!?
>> I just started on a project for one of my clients for which I would like to identify unmet or poorly-met medical needs that
could be addressed by drug delivery
>> Does anyone know of an effort to look at these delivery opportunities in a systematic way, e.g., by drug or by
therapeutic area? The range of opportunities I a
>> Any pointers or a discussion of this topic would be appreciated.
> Cheers,
>> Thomas Collet
> McKinsey&Company, Inc.
>Thomas_Collet at McKinsey.com>tacollet at tezcat.com
Thomas,
I can almost guarantee you that any such database is proprietary.
Consulting firms prepare them for drug delivery firms who then
realize that the new databases are identical to previous ones
prepared in-house.
An interesting comment on our iterative times, don't you think?
Bill Graney
